Buscar resultados de ensayos clínicos
Medulloblastoma - 50 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma Condición: High-risk Medulloblastoma Fecha: 2013-12-30 Intervenciones:
|
Completed |
Nombre del estudio: Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma Condición: Recurrent Childhood Medulloblastoma Fecha: 2010-11-10 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma Condición: Untreated Childhood Medulloblastoma Fecha: 2016-03-25 Intervenciones:
|
Completed |
Nombre del estudio: Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma Condición: Untreated Childhood Medulloblastoma Fecha: 2013-12-13 Intervenciones:
|
Completed |
Nombre del estudio: GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment Condición: Recurrent Childhood Medulloblastoma Fecha: 2009-01-13 Intervenciones:
|
Completed |
Nombre del estudio: Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Condición: Untreated Childhood Medulloblastoma Fecha: 2004-06-14 Intervenciones:
|
Withdrawn |
Nombre del estudio: A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma Condición:
Fecha: 2012-09-28 Intervenciones:
|
Recruiting |
Nombre del estudio: Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway Condición:
|
Recruiting |
Nombre del estudio: Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Condición:
Fecha: 2010-07-22 Intervenciones:
|
Terminated |
Nombre del estudio: Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma Condición:
Fecha: 2011-11-28 Intervenciones: Drug: TPI 287 Subjects will receive six cycles of intravenous (IV) TPI 287 at a dose of 125 mg/m2 on Day |